ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 326,47
0,56%
Dow Jones
38 980,25
2,12%
DAX
21 293,53
0,45%
Brent Oil
66,965
1,76%
Bitcoin
90 794,86
3,74%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Amarin Corporation PLC (AMRN)

  7. Amarin Corporation PLC (AMRN) Actualités

AMRN

Amarin (AMRN)

Amarin Corporation PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AMRN
DateHeureSourceTitreSymboleSociété
12/04/202500h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AMRNAmarin Corporation PLC
10/04/202523h01Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AMRNAmarin Corporation PLC
10/04/202513h30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AMRNAmarin Corporation PLC
09/04/202513h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRNAmarin Corporation PLC
09/04/202513h30GlobeNewswire Inc.Amarin Confirms Effective Date for 1-For-20 ADS Ratio ChangeNASDAQ:AMRNAmarin Corporation PLC
09/04/202513h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corporation PLC
07/04/202513h50Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:AMRNAmarin Corporation PLC
07/04/202513h30GlobeNewswire Inc.Amarin Appoints JEC Capital Partners’ Michael Torok to Board of DirectorsNASDAQ:AMRNAmarin Corporation PLC
31/03/202514h00GlobeNewswire Inc.Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 AgonistNASDAQ:AMRNAmarin Corporation PLC
28/03/202521h45Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AMRNAmarin Corporation PLC
26/03/202501h37Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AMRNAmarin Corporation PLC
19/03/202512h30GlobeNewswire Inc.New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of CarNASDAQ:AMRNAmarin Corporation PLC
12/03/202512h46Edgar (US Regulatory)Form F-6 POS - Post-effective amendments for immediately effective filingNASDAQ:AMRNAmarin Corporation PLC
12/03/202512h01GlobeNewswire Inc.Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) ProgramNASDAQ:AMRNAmarin Corporation PLC
12/03/202512h00GlobeNewswire Inc.Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action NASDAQ:AMRNAmarin Corporation PLC
27/02/202515h00GlobeNewswire Inc.Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol LoweringNASDAQ:AMRNAmarin Corporation PLC
25/02/202514h00GlobeNewswire Inc.Amarin Receives National Reimbursement for VAZKEPA® in AustriaNASDAQ:AMRNAmarin Corporation PLC
19/02/202514h30GlobeNewswire Inc.Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025NASDAQ:AMRNAmarin Corporation PLC
16/12/202413h00GlobeNewswire Inc.Amarin Receives National Reimbursement for VAZKEPA® in ItalyNASDAQ:AMRNAmarin Corporation PLC
13/12/202415h00GlobeNewswire Inc.Amarin Appoints Peter Fishman Chief Financial OfficerNASDAQ:AMRNAmarin Corporation PLC
11/11/202414h00GlobeNewswire Inc.Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) AnnualNASDAQ:AMRNAmarin Corporation PLC
30/10/202421h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AMRNAmarin Corporation PLC
30/10/202421h05GlobeNewswire Inc.Amarin Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:AMRNAmarin Corporation PLC
01/10/202414h00GlobeNewswire Inc.Amarin Announces Two Upcoming Investor EventsNASDAQ:AMRNAmarin Corporation PLC
09/09/202413h30GlobeNewswire Inc.Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual EuropeNASDAQ:AMRNAmarin Corporation PLC
22/08/202414h30GlobeNewswire Inc.Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) CongressNASDAQ:AMRNAmarin Corporation PLC
31/07/202413h00GlobeNewswire Inc.Amarin Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:AMRNAmarin Corporation PLC
17/07/202422h15GlobeNewswire Inc.Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in PortugalNASDAQ:AMRNAmarin Corporation PLC
17/07/202414h00GlobeNewswire Inc.Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024NASDAQ:AMRNAmarin Corporation PLC
08/07/202413h30GlobeNewswire Inc.Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR)NASDAQ:AMRNAmarin Corporation PLC
 Showing the most relevant articles for your search:NASDAQ:AMRN

Dernières Valeurs Consultées

USOTC
NWOEF
New Oriental Education &... (PK)
NASDAQ
CBTMX
Ci Canadian Bond Fund Cl...
USOTC
PINXY
Peoples Insurance Compan... (PK)
NASDAQ
NYMTI
New York Mortgage
ASX
WBCHCX
Westpac Banking
COIN
ARBBBTC
ARBITRAGE
COIN
MSOLUSD
Marinade staked SOL
USOTC
STPJF
Southern Pacific Resource (CE)
COIN
APESETH
APE Punk
NASDAQ
CACNX
Canoe Asset Allocation P...
COIN
CGTBTC
CACHE Gold
BIT
S29361
Societe Generale Effekten
BIT
UC3XAM
Unicredit Bank
COIN
CHGBTC
Charg Coin
BIT
UB7RUU
Unicredit Bank
USOTC
NDTAF
Northern Data AG INH O N (PK)
Delayed Upgrade Clock
ADVFN Logo
France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces